ASTH (Astrana Health) Growth Rank: 10 (As of Jul. 08, 2026) — 25% Above Median


ASTH Astrana Health Inc ASTH
87 GF Score
Price $46.28
GF Value $82.83
Valuation Significantly Undervalued
! 8 Warning Signs
View Full Analysis

What is Astrana Health Growth Rank?

Astrana Health ASTH -1.62% 87 Growth Rank is 10 as of Jul. 08, 2026, which is 25% above its 10-year median of 8.00. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.83 (Significantly Undervalued). The stock has 8 warning signs investors should review.

Astrana Health has the Growth Rank of 10.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Astrana Health Growth Rank Related Terms

ASTH vs SGRY, SEM, MD: Growth Rank Comparison

For the Medical Care Facilities subindustry, Astrana Health's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astrana Health Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Growth Rank distribution charts can be found below:

* The bar in red indicates where Astrana Health's Growth Rank falls into.


ASTH
87GF Score
Astrana Health Inc ASTH
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 10 mean?
Astrana Health (ASTH) has a Growth Rank of 10 as of Jul. 08, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Astrana Health and its competitors. This is 25% above median its historical median of 8.00. Over the past decade, Astrana Health's Growth Rank has ranged from 2.00 to 10.00.
Is Astrana Health's Growth Rank too high?
Astrana Health's current Growth Rank of 10 is 25% above median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 10.00. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Growth Rank compare to SGRY and SEM?
Astrana Health's Growth Rank of 10 can be compared against companies in the Healthcare Providers & Services industry. Historically, Astrana Health's own Growth Rank has ranged from 2.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Astrana Health and its competitors. Astrana Health's current Growth Rank is 10, which is 25% above median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.83, compared to a current price of $46.28 — trading 44.1% below its estimated fair value. The current Growth Rank is 10, which is 25% above median its 10-year median of 8.00. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Astrana Health (ASTH), the current Growth Rank is 10 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $46.28 is trading 44.1% below its estimated GF Value™ of $82.83. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

  • Growth Rank: 10 (25% above median its 10-year median of 8.00)
  • GF Value™: $82.83 vs. price of $46.28 (44.1% below fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astrana Health Business Description

Other Exchanges 3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score

Get the complete analysis for ASTH

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$46.28
Price
$82.83
GF Value